日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas

NFKBIA 单倍体不足重塑了与 IDH 突变相反的表观基因组，并决定了弥漫性胶质瘤的疾病命运

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2023.101082
Markus Bredel, Lluís Espinosa, Hyunsoo Kim, Denise M Scholtens, Joseph P McElroy, Rajani Rajbhandari, Wei Meng, Thomas M Kollmeyer, Tathiane M Malta, Michael A Quezada, Griffith R Harsh, Teresa Lobo-Jarne, Laura Solé, Aran Merati, Surya Nagaraja, Sindhu Nair, Jaclyn J White, Nanda K Thudi, Jessica L
神经
肿瘤
胶质瘤
FCM
IF
IHC-P
WB
发表日期：2023
文献求助 收藏

Durable clinical response to the multidisciplinary management of neurosurgery, radiation and chemoimmunotherapy in a patient with PD-L1/PD-L2/JAK2 (PDJ)-amplified, refractory triple-negative breast cancer

PD-L1/PD-L2/JAK2 (PDJ) 扩增的难治性三阴性乳腺癌患者经神经外科、放射治疗和化疗免疫疗法的多学科综合治疗后获得持久的临床疗效

期刊:Journal of the National Cancer Center
影响因子:9.4
doi:10.1016/j.jncc.2021.07.004
Zhao, Hongyuan; Ma, Weijie; Fragoso, Ruben C; Iv, Griffith R Harsh; Ashok, Arya; Li, Tianhong
肿瘤
肿瘤免疫
JAK/STAT
乳腺癌
JAK2
PD-L1
免疫/内分泌
发表日期：2021
文献求助 收藏

Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression

富含大脑的替代外显子的谱系特异性剪接促进胶质母细胞瘤进展

期刊:Journal of Clinical Investigation
影响因子:13.3
doi:10.1172/JCI68836
Roberto Ferrarese, Griffith R Harsh 4th, Ajay K Yadav, Eva Bug, Daniel Maticzka, Wilfried Reichardt, Stephen M Dombrowski, Tyler E Miller, Anie P Masilamani, Fangping Dai, Hyunsoo Kim, Michael Hadler, Denise M Scholtens, Irene L Y Yu, Jürgen Beck, Vinodh Srinivasasainagendra, Fabrizio Costa, Nicolet
细胞生物学
肿瘤
胶质瘤
其它细胞
发表日期：2014
文献求助 收藏